Attenteo V2

Attenteo V2

Improve your attention & ADHD

8 ratings
7 reviews
Free
With Ads

Details

  • Released
  • Updated
  • December 13, 2025
  • May 9, 2026

Features

Attenteo V2 screenshot #1 for iPhone
Attenteo V2 screenshot #2 for iPhone
Attenteo V2 screenshot #3 for iPhone
Attenteo V2 screenshot #4 for iPhone
Attenteo V2 screenshot #5 for iPhone
Attenteo V2 screenshot #6 for iPhone
🖼️Get Icon
Icons↘︎

About

This therapeutic app uses cognitive neuroscience to improve attention and address the root cause of ADHD. Clinical trials show significant improvements in attention span and reduced distraction in users. It offers rapid relief from symptoms in as little as four minutes.

Drug-free therapeutic approach
Advanced cognitive neuroscience
Personalized avatar guide
Rapid symptom relief
Clinical trial validated improvements
Show original description

What's New in Attenteo V2

2.2.1

May 9, 2026

This new version incorporates an updated onboarding experience and tutorial, the incorporation of Routine Builder - a mini application that can help you optimize your days, revised animations and of course, we eliminated a few bugs.

More

User reviews

I like Attenteo

I’ve tried dozens of productivity apps, but this one is different. The patented method they use really clicks with the way my brain works. It’s helped me cut through the mental fog and actually get things done without feeling overwhelmed. Highly recommend for anyone struggling with focus.

Helps my scattered ADHD attention

I’ve been using this for a couple of weeks and the biggest difference I’ve notice is how much easier it’s been to “reset” my attention.

I tend to spiral or go into overdrive with thoughts/to-dos & my ADHD. This definitely seems to help me slow down and re-calibrate my attention when I get scattered or interrupted.

I like most that it doesn’t feel demanding like some “productivity” focused adhd-apps. No guilt around not crossing off to-dos or having to lock myself out of apps to focus. Just helps me with attention when I need it. It’s subtle but I suspect with continued use, could definitely build benefits better long term.
Show more

Super App

Really like this app! it’s super easy to use and gives me relief whenever i’m feeling anxious. Definitely helps me stabilize and stay focused.

So grounding

Very calming. Can tell this going to be a game changer for my focus and sleep!

This works!

Finally, something that clicks with my ADHD. Not just another organization app or day planner. Highly recommend!

Developer apps

FAQ

What is Attenteo V2?

Attenteo V2 is a therapeutic mobile application designed to improve attention and address the root causes of ADHD using advanced cognitive neuroscience. It aims to provide a drug-free alternative for managing attention dysfunction.

How effective is Attenteo V2?

In clinical trials conducted at UCLA and UC Berkeley, nearly 90% of users reported improvements in their ability to pay attention, stay focused, and be less distracted after seven weeks of use. Users also report feeling rapid relief from ADHD symptoms in as little as four minutes.

Does Attenteo V2 require a subscription?

No, Attenteo V2 is available for download for free. The app is supported by advertisements, as indicated by its monetization model.

What devices does Attenteo V2 support?

Attenteo V2 is currently supported on iPhone and iPod devices. It is not specified if it is available on Android or other platforms.

What is the age rating for Attenteo V2?

Attenteo V2 has an age rating of 17+. This suggests content that may not be suitable for younger individuals.

How often is Attenteo V2 updated?

The latest version of Attenteo V2 is 1.0, and it was last updated on December 13, 2025. Further information on update frequency is not provided.

Does Attenteo V2 have ads?

Yes, Attenteo V2 contains advertisements. This is part of its ad-supported monetization model.

What is the science behind Attenteo V2?

The core technology of Attenteo V2 was developed with significant funding from the National Institute of Mental Health (NIMH), totaling $7.2M in grants. This funding supported the primary research and clinical trials focused on attention dysfunction.